This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Shanghai Abelzeta Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Shichao Qin: Innovator in Tumor-Infiltrating Lymphocyte Expansion
Introduction
Shichao Qin is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer research, particularly in the area of tumor-infiltrating lymphocytes (TILs). His innovative methods have the potential to enhance cancer treatment by improving the availability of TILs for therapeutic use.
Latest Patents
Shichao Qin holds a patent for "Methods for preparing tumor-infiltrating lymphocytes." This patent describes methods for expanding TILs, which include co-culturing an initial cell population containing TILs with first feeder cells to obtain a first expanded cell population. Subsequently, the first expanded cell population is co-cultured with second feeder cells to obtain an expanded TIL population. These methods can quickly produce a large number of TILs from a small tumor sample, showcasing his innovative approach to cancer therapy.
Career Highlights
Shichao Qin is associated with Shanghai Abelzeta Ltd., where he continues to work on advancing cancer treatment methodologies. His dedication to research and development has positioned him as a key figure in the field of immunotherapy.
Collaborations
Shichao collaborates with notable colleagues, including Jia Li and Jiyan Hou. Their combined expertise contributes to the ongoing research and development efforts at Shanghai Abelzeta Ltd.
Conclusion
Shichao Qin's work in expanding tumor-infiltrating lymphocytes represents a significant advancement in cancer treatment methodologies. His innovative approaches and collaborations are paving the way for more effective therapies in the fight against cancer.